Opaleye Management as of March 31, 2022
Portfolio Holdings for Opaleye Management
Opaleye Management holds 45 positions in its portfolio as reported in the March 2022 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Ocular Therapeutix (OCUL) | 9.2 | $30M | 6.0M | 4.95 | |
| Codexis (CDXS) | 8.6 | $28M | 1.3M | 20.62 | |
| Chimerix (CMRX) | 8.4 | $27M | 5.9M | 4.58 | |
| Harrow Health (HROW) | 7.0 | $22M | 3.3M | 6.82 | |
| Crinetics Pharmaceuticals In (CRNX) | 4.7 | $15M | 693k | 21.95 | |
| Cytokinetics Com New (CYTK) | 4.6 | $15M | 407k | 36.81 | |
| Keros Therapeutics (KROS) | 4.5 | $15M | 266k | 54.38 | |
| Protara Therapeutics Com Stk (TARA) | 4.2 | $14M | 2.7M | 5.11 | |
| Reata Pharmaceuticals Class A | 4.1 | $13M | 407k | 32.76 | |
| Kiniksa Pharmaceuticals Com Cl A (KNSA) | 3.4 | $11M | 1.1M | 9.94 | |
| Eton Pharmaceuticals (ETON) | 3.2 | $10M | 2.4M | 4.36 | |
| Merus N V (MRUS) | 2.8 | $8.9M | 338k | 26.44 | |
| Stereotaxis Com New (STXS) | 2.8 | $8.9M | 2.4M | 3.73 | |
| Tracon Pharmaceuticals Com New (TCON) | 2.6 | $8.3M | 3.2M | 2.63 | |
| Bicycle Therapeutics Sponsored Ads (BCYC) | 2.4 | $7.7M | 175k | 43.88 | |
| Xoma Corp Del Com New (XOMA) | 2.4 | $7.6M | 271k | 27.98 | |
| Celldex Therapeutics Com New (CLDX) | 2.1 | $6.7M | 196k | 34.06 | |
| Protagonist Therapeutics (PTGX) | 1.8 | $6.0M | 252k | 23.68 | |
| Tela Bio (TELA) | 1.7 | $5.5M | 477k | 11.63 | |
| Fortress Biotech | 1.6 | $5.1M | 3.8M | 1.36 | |
| Vaxcyte (PCVX) | 1.6 | $5.1M | 211k | 24.15 | |
| 4d Molecular Therapeutics In (FDMT) | 1.5 | $4.9M | 325k | 15.12 | |
| Larimar Therapeutics (LRMR) | 1.2 | $3.8M | 944k | 4.05 | |
| Ginkgo Bioworks Holdings Class A Shares (DNA) | 1.2 | $3.7M | 930k | 4.03 | |
| Semler Scientific (SMLR) | 1.1 | $3.5M | 70k | 49.56 | |
| Macrogenics (MGNX) | 1.0 | $3.3M | 376k | 8.81 | |
| Verastem | 1.0 | $3.3M | 2.3M | 1.41 | |
| Fulcrum Therapeutics (FULC) | 1.0 | $3.2M | 136k | 23.65 | |
| 908 Devices (MASS) | 1.0 | $3.2M | 166k | 19.01 | |
| Edgewise Therapeutics (EWTX) | 0.9 | $2.9M | 303k | 9.70 | |
| Mersana Therapeutics (MRSN) | 0.9 | $2.8M | 710k | 3.99 | |
| Hyperfine Com Cl A (HYPR) | 0.8 | $2.7M | 763k | 3.54 | |
| Synlogic | 0.7 | $2.4M | 984k | 2.40 | |
| Proqr Therapeutics Nv Shs Euro (PRQR) | 0.7 | $2.2M | 2.4M | 0.91 | |
| Neoleukin Therapeutics | 0.5 | $1.5M | 790k | 1.88 | |
| Aveo Pharmaceuticals Com New | 0.4 | $1.3M | 240k | 5.59 | |
| Graphite Bio | 0.4 | $1.3M | 256k | 5.10 | |
| Liquidia Corporation Com New (LQDA) | 0.4 | $1.3M | 179k | 7.18 | |
| Modular Medical Com New (MODD) | 0.4 | $1.2M | 266k | 4.40 | |
| Avalo Therapeutics | 0.3 | $1.1M | 1.5M | 0.72 | |
| Nucana Sponsored Adr (NCNA) | 0.3 | $878k | 879k | 1.00 | |
| Repare Therapeutics Ord (RPTX) | 0.2 | $793k | 56k | 14.24 | |
| Sutro Biopharma (STRO) | 0.2 | $740k | 90k | 8.22 | |
| Journey Med Corp (DERM) | 0.1 | $324k | 67k | 4.84 | |
| Biolinerx Sponsored Ads (BLRX) | 0.0 | $29k | 17k | 1.74 |
